| Patient Reported Outcomes, Smart Pill Bottle and Teleheath for Endocrine Therapy Adherence (NCT04054557) | Thomas Jefferson University | 2019-07-31 |
| SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer (NCT03411070) | Jonsson Comprehensive Cancer Center | 2019-04-07 |
| Phase I Trial of Endoxifen Gel Versus Placebo in Women Undergoing Breast Surgery (NCT03317405) | National Cancer Institute (NCI) | 2018-10-31 |
| Hypofractionated Radiation Therapy in Preventing Recurrence in Patients With Breast Cancer After Surgery (NCT03324802) | Mayo Clinic | 2018-02-07 |
| Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors (NCT03319342) | Jonsson Comprehensive Cancer Center | 2017-07-11 |
| Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer (NCT03012100) | Academic and Community Cancer Research United | 2017-03-31 |
| Multicenter Trial for Eliminating Breast Cancer Surgery or Radiotherapy in Exceptional Responders to Neoadjuvant Systemic Therapy (NCT02945579) | M.D. Anderson Cancer Center | 2017-01-20 |
| Alternative Dosing of Exemestane Before Surgery in Treating Postmenopausal Patients With Stage 0-II Estrogen Positive Breast Cancer (NCT02598557) | National Cancer Institute (NCI) | 2016-12-06 |
| Women's MoonShot: Neoadjuvant Treatment With PaCT for Patients With Locally Advanced TNBC (NCT02593175) | M.D. Anderson Cancer Center | 2016-11-03 |
| Enzalutamide and Paclitaxel Before Surgery in Treating Patients With Stage I-III Androgen Receptor-Positive Triple-Negative Breast Cancer (NCT02689427) | M.D. Anderson Cancer Center | 2016-09-22 |
| Electroacupuncture Therapy in Reducing Chronic Pain in Patients After Breast Cancer Treatment (NCT02754752) | M.D. Anderson Cancer Center | 2016-09-13 |
| Molecular Testing and Imaging in Improving Response in Patients With Stage I-III Triple-Negative Breast Cancer Receiving Chemotherapy MDACC Breast Moonshot Initiative (NCT02276443) | M.D. Anderson Cancer Center | 2015-11-09 |
| Sensorimotor Rehabilitation Program in Improving Quality of Life in Patients With Early Stage Breast Cancer (NCT03568526) | Ohio State University Comprehensive Cancer Center | 2015-07-02 |
| Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer (NCT02003209) | National Cancer Institute (NCI) | 2014-02-18 |
| Chemotherapy With or Without Trastuzumab After Surgery in Treating Women With Invasive Breast Cancer (NCT01275677) | National Cancer Institute (NCI) | 2011-02-08 |
| Hypofractionated Radiation Therapy or Standard Radiation Therapy in Treating Patients With Ductal Breast Carcinoma In Situ or Early Invasive Breast Cancer (NCT01266642) | M.D. Anderson Cancer Center | 2011-02-08 |
| Radiation Therapy in Treating Patients With Stage 0-II Breast Cancer (NCT01245712) | M.D. Anderson Cancer Center | 2010-11-15 |
| Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial) (NCT00310180) | National Cancer Institute (NCI) | 2006-04-07 |
| Doxorubicin Hydrochloride, Cyclophosphamide, and Pacltaxel With or Without Trastuzumab in Treating Women With HER2-Positive Node-Positive or High-Risk Node-Negative Breast Cancer (NCT00005970) | National Cancer Institute (NCI) | 2000-05-19 |